Related references
Note: Only part of the references are listed.European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery
Yan-Long Han et al.
MEDICINE (2018)
Early recognition of aggressive pituitary adenomas: a single-centre experience
Filippo Ceccato et al.
ACTA NEUROCHIRURGICA (2018)
How effective is temozolomide for treating pituitary tumours and when should it be used?
Carmel Halevy et al.
PITUITARY (2017)
Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review
Mussa H. Almalki et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2017)
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas
Ilan Shimon et al.
PITUITARY (2016)
THERAPY OF ENDOCRINE DISEASE The challenges in managing giant prolactinomas
Dominique Maiter et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
Laurent Vroonen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Share Paper
